Table 4.
Placebo | Elafin | |||
---|---|---|---|---|
Postoperative complications and outcomes (48 h) | ||||
Death | 0 | (0) | 0 | (0) |
Stroke | 0 | (0) | 0 | (0) |
Myocardial infarction | 0 | (0) | 1 | (2.3) |
Inotrope or balloon pump support for >24 h | 10 | (27.3) | 12 | (23.3) |
Red cell transfusion postoperative | 12 | (27.9) | 12 | (27.3) |
Reoperation for bleeding | 2 | (4.7) | 1 | (2.3) |
Respiratory complications | 3 | (7.0) | 5 | (11.4) |
Antibiotic administration | 2 | (4.7) | 4 | (9.1) |
Atrial fibrillation | 4 | (9.3) | 3 | (6.8) |
Serum creatinine (mg/dL) | ||||
24 h | 0.90±0.32 | 0.87±0.32 | ||
48 h | 0.96±0.48 | 0.88±0.42 |
Data are number of patients (%) or mean±SD.